These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14640824)

  • 21. Current pharmacotherapy for gambling disorder: a systematic review.
    Kraus SW; Etuk R; Potenza MN
    Expert Opin Pharmacother; 2020 Feb; 21(3):287-296. PubMed ID: 31928246
    [No Abstract]   [Full Text] [Related]  

  • 22. Naltrexone in the Treatment of Broadly Defined Behavioral Addictions: A Review and Meta-Analysis of Randomized Controlled Trials.
    Mouaffak F; Leite C; Hamzaoui S; Benyamina A; Laqueille X; Kebir O
    Eur Addict Res; 2017; 23(4):204-210. PubMed ID: 28877518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathological gambling: focusing on the addiction, not the activity.
    Tamminga CA; Nestler EJ
    Am J Psychiatry; 2006 Feb; 163(2):180-1. PubMed ID: 16449466
    [No Abstract]   [Full Text] [Related]  

  • 24. Short-term single-blind fluvoxamine treatment of pathological gambling.
    Hollander E; DeCaria CM; Mari E; Wong CM; Mosovich S; Grossman R; Begaz T
    Am J Psychiatry; 1998 Dec; 155(12):1781-3. PubMed ID: 9842795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study.
    Dannon PN; Lowengrub K; Musin E; Gonopolsky Y; Kotler M
    J Clin Psychopharmacol; 2007 Dec; 27(6):620-4. PubMed ID: 18004130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid receptor antagonists in the treatment of pathological gambling.
    Coppola M; Mondola R
    J Opioid Manag; 2017; 13(4):205-206. PubMed ID: 28983886
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacological treatment of pathological gambling].
    Pallesen S; Molde H; Arnestad HM; Skutle A; Menzoni R; Holsten F
    Tidsskr Nor Laegeforen; 2006 May; 126(10):1322-4. PubMed ID: 16691267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges.
    Grant JE; Kim SW; Hartman BK
    J Clin Psychiatry; 2008 May; 69(5):783-9. PubMed ID: 18384246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid antagonist naltrexone for the treatment of pathological gambling in Parkinson disease.
    Bosco D; Plastino M; Colica C; Bosco F; Arianna S; Vecchio A; Galati F; Cristiano D; Consoli A; Consoli D
    Clin Neuropharmacol; 2012; 35(3):118-20. PubMed ID: 22426027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twelve-step facilitated versus mapping-enhanced cognitive-behavioral therapy for pathological gambling: a controlled study.
    Marceaux JC; Melville CL
    J Gambl Stud; 2011 Mar; 27(1):171-90. PubMed ID: 20490632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological gambling: an update on neuropathophysiology and pharmacotherapy.
    Iancu I; Lowengrub K; Dembinsky Y; Kotler M; Dannon PN
    CNS Drugs; 2008; 22(2):123-38. PubMed ID: 18193924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a web-based self-help tool to reduce problem gambling in Switzerland: study protocol of a two-armed randomised controlled trial.
    Baumgartner C; Bilevicius E; Khazaal Y; Achab S; Schaaf S; Wenger A; Haug S; Keough M; Hodgins D; Schaub MP
    BMJ Open; 2019 Dec; 9(12):e032110. PubMed ID: 31818841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The psychopharmacology of pathological gambling.
    Kim SW; Grant JE
    Semin Clin Neuropsychiatry; 2001 Jul; 6(3):184-94. PubMed ID: 11447570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
    Farren CK; Scimeca M; Wu R; Malley SO
    Drug Alcohol Depend; 2009 Jan; 99(1-3):317-21. PubMed ID: 18644685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problems in measuring the effectiveness of cognitive therapy for pathological gambling.
    Walker MB
    J Gambl Stud; 2005; 21(1):79-92. PubMed ID: 15789193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naltrexone as negative reinforcement comments on "A behavioral analysis of coerced treatment for addicted offenders".
    Farabee D
    J Subst Abuse Treat; 2006 Sep; 31(2):141-2. PubMed ID: 16919740
    [No Abstract]   [Full Text] [Related]  

  • 37. Group therapy for pathological gamblers: a cognitive approach.
    Ladouceur R; Sylvain C; Boutin C; Lachance S; Doucet C; Leblond J
    Behav Res Ther; 2003 May; 41(5):587-96. PubMed ID: 12711266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary investigation of abstinence and controlled gambling as self-selected goals of treatment for female pathological gambling.
    Dowling N; Smith D; Thomas T
    J Gambl Stud; 2009 Jun; 25(2):201-14. PubMed ID: 19199009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
    Victorri-Vigneau C; Spiers A; Caillet P; Bruneau M; Ignace-Consortium ; Challet-Bouju G; Grall-Bronnec M
    Curr Neuropharmacol; 2018; 16(10):1418-1432. PubMed ID: 28721822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pathological gambling.
    Leung KS; Cottler LB
    Curr Opin Psychiatry; 2009 Jan; 22(1):69-74. PubMed ID: 19122538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.